SBP-7455 namic acid sodium Smiles: CC1=CC(=O)O[C@H]2C[C@H]3O[C@H]4C[C@@H](C)[C@H]5O[C@H]6C[C@H]7O[C@@]8(C)CC=C[C@H]9O[C@H]%10C[C@H]%11O[C@@H](C[C@H](O)[C@]%11(C)O[C@@H]%10C[C@@H]9O[C@@H]8C[C@]7(C)O[C@]6(C)CC[C@@H]5O[C@@H]4C[C@]3(C)O[C@H]12)CC(=C)C=O |c:23|

Smiles: CC1=CC(=O)O[C@H]2C[C@H]3O[C@H]4C[C@@H](C)[C@H]5O[C@H]6C[C@H]7O[C@@]8(C)CC=C[C@H]9O[C@H]%10C[C@H]%11O[C@@H](C[C@H](O)[C@]%11(C)O[C@@H]%10C[C@@H]9O[C@@H]8C[C@]7(C)O[C@]6(C)CC[C@@H]5O[C@@H]4C[C@]3(C)O[C@H]12)CC(=C)C=O |c:23|

Gadodiamide injection produces less severe alterations in hemodynamics than gadopentetate dimeglumine

SLV313 possessed high affinity at human recombinant D(2)

H2O/c1-18-16-27(12-11-25(18

SBP-7455 namic acid sodium Smiles: CC1=CC(=O)O[C@H]2C[C@H]3O[C@H]4C[C@@H](C)[C@H]5O[C@H]6C[C@H]7O[C@@]8(C)CC=C[C@H]9O[C@H]%10C[C@H]%11O[C@@H](C[C@H](O)[C@]%11(C)O[C@@H]%10C[C@@H]9O[C@@H]8C[C@]7(C)O[C@]6(C)CC[C@@H]5O[C@@H]4C[C@]3(C)O[C@H]12)CC(=C)C=O |c:23|SBP 7455 is a potent, high affinity and orally active dual ULK1 ULK2 autophagy inhibitor with IC50s of 13 nM and 476 nM in the ADP Glo assays, respectively. SBP 7455 potently inhibits ULK1 2 enzymatic activity and can be used for triple negative breast cancer (TNBC) research. Product information CAS Number: 1884222 74 5 Molecular Weight: 354. 33 Formula: C16H17F3N4O2 Chemical Name: N4 cyclopropyl N2 (3,4 dimethoxyphenyl) 5 (trifluoromethyl)pyrimidine